Correspondence 0001493152-23-003816 from THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI) (CIK 0001419051)
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI) (CIK 0001419051)
Date: Feb. 7, 2023 · CIK: 0001419051 · Accession: 0001493152-23-003816
AI Filing Summary & Sentiment
File numbers found in text: 333-268070
Letter
Wild Rose Lane
Elk City, ID, 83525
Oceanside Blvd. Suite B
Oceanside, CA, 92056
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Industrial Applications and Services
F Street, N.E.
Washington, D.C. 20549-7561
Re: Therapeutic Solutions International, Inc. (TSOI)
Registration Statement on Form S-1A
File No.: 333-268070
February 7, 2023
Ladies and Gentlemen:
This correspondence is Therapeutic Solutions International, Inc.’s, (“TSOI”) response to your comments letter of February 6, 2023 and describes how each of the comments has been addressed in the amended filing of February 7, 2023, S-1A, Amendment Four (4).
Executive Compensation, page 46
Comment 1. We note your revisions in response to our prior comment 2. Please ensure that Footnotes 1 and 2 of your table consistently apply to the years they reference. For example, it appears that Footnote 1, which is next to Timothy G. Dixon’s 2022 salary figure, refers to compensation that was accrued and paid in 2021.
Response: The compensation disclosure has been updated as of the recently completed fiscal year ended December 31, 2022 and the Footnotes 1 and 2 now correspond accordingly.
It would be appreciated if, as soon practicable, you would inform the company and Hugh Kelso at (619) 840-5056, if there are any additional actions required
Very
truly yours,
Therapeutic
Solutions International, Inc.
Show Raw Text
CORRESP
1
filename1.htm
701
Wild Rose Lane
Elk City, ID, 83525
4093
Oceanside Blvd. Suite B
Oceanside, CA, 92056
U.S.
Securities and Exchange Commission
Division
of Corporate Finance
Office
of Industrial Applications and Services
100
F Street, N.E.
Washington,
D.C. 20549-7561
Re:
Therapeutic
Solutions International, Inc. (TSOI)
Registration
Statement on Form S-1A
File
No.: 333-268070
February
7, 2023
Ladies
and Gentlemen:
This
correspondence is Therapeutic Solutions International, Inc.’s, (“TSOI”) response to your comments letter of February
6, 2023 and describes how each of the comments has been addressed in the amended filing of February 7, 2023, S-1A, Amendment Four (4).
Executive
Compensation, page 46
Comment
1. We note your revisions in response to our prior comment 2. Please ensure that Footnotes 1 and 2 of your table consistently
apply to the years they reference. For example, it appears that Footnote 1, which is next to Timothy G. Dixon’s 2022 salary figure,
refers to compensation that was accrued and paid in 2021.
Response:
The compensation disclosure has been updated as of the recently completed fiscal year ended December 31, 2022 and the Footnotes 1 and
2 now correspond accordingly.
It
would be appreciated if, as soon practicable, you would inform the company and Hugh Kelso at (619) 840-5056, if there are any additional
actions required
Very
truly yours,
Therapeutic
Solutions International, Inc.
By:
/s/:
Timothy G. Dixon
Timothy
G. Dixon
Chief
Executive Officer